Pharmacological and Toxicological Studies on Triosil, an Intravenous Contrast Agent

1962 ◽  
Vol 35 (420) ◽  
pp. 815-823 ◽  
Author(s):  
Dorothy Busfield ◽  
K. J. Child ◽  
E. G. Tomich
Keyword(s):  
Contrast Agent ◽  
Intravenous Contrast ◽  
Toxicological Studies ◽  
Intravenous Contrast Agent

The Role of Intravenous Contrast Agent in the Sonographic Assessment of Crohn’s Disease Activity: Is Contrast Agent Injection Necessary?

2018 ◽  
Vol 13 (5) ◽  
pp. 585-592 ◽  
Author(s):  
Tomás Ripollés ◽  
María Jesús Martínez-Pérez ◽  
José María Paredes ◽  
José Vizuete ◽  
Gregorio Martin
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Contrast Agent ◽  
Disease Activity ◽  
Intravenous Contrast ◽  
Sonographic Assessment ◽  
Contrast Agent Injection ◽  
Crohn’S Disease Activity ◽  
Intravenous Contrast Agent

Angiographic CT with intravenous contrast agent application for monitoring of intracranial flow diverting stents

2011 ◽  
Vol 54 (7) ◽  
pp. 727-735 ◽  
Author(s):  
Marc Saake ◽  
Tobias Struffert ◽  
Philipp Goelitz ◽  
Sabine Ott ◽  
Frank Seifert ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Intravenous Contrast ◽  
Angiographic Ct ◽  
Intravenous Contrast Agent

scholarly journals Intravenous Contrast Agent in Abdominal CT: Is It Really Needed to Identify the Cause of Bowel Obstruction? Proof of Concept

2019 ◽  
Vol 2019 ◽  
pp. 1-6
Author(s):  
Federica Vernuccio ◽  
Dario Picone ◽  
Gregorio Scerrino ◽  
Massimo Midiri ◽  
Giuseppe Lo Re ◽  
...  
Keyword(s):  
Small Bowel ◽  
Contrast Agent ◽  
Small Bowel Obstruction ◽  
Bowel Obstruction ◽  
Large Bowel ◽  
Large Bowel Obstruction ◽  
Intravenous Contrast ◽  
Unenhanced Ct ◽  
Enhanced Ct ◽  
Intravenous Contrast Agent

Background. To compare sensitivity of unenhanced computed tomography (CT) and contrast-enhanced CT for the identification of the etiology of bowel obstruction. Materials and Methods. We retrospectively evaluated abdominal CT scans of patients operated for bowel obstruction from March 2013 to October 2017. Two radiologists evaluated CT scans before and after contrast agent in two reading sessions. Then, we calculated sensitivity of CT in the diagnosis of bowel obstruction and determined in which cases the etiology of bowel obstruction was detected on both unenhanced and enhanced CT or on enhanced CT only. The reference standard was defined as the final diagnosis obtained after surgery. Results. Eighteen patients (mean age 72±15 years, age range 37-88 years) were included in the study. Sensitivity of unenhanced CT and enhanced CT was not significantly different in either small bowel obstruction (64%, 7/11 patients vs. 73%, 8/11 patients; P=0.6547) or large bowel obstruction (71%, 5/7 patients vs. 100%, 7/7 patients; P=0.1410). Adhesions were identified on unenhanced CT as the etiology of small bowel obstruction in 80% (4/5) of patients. Tumors were identified on unenhanced CT as the etiology of large bowel obstruction in 67% (4/6) of patients. Conclusion. In the diagnosis of small bowel obstruction due to adhesions with normal bowel wall thickening and when a neoplasm is identified as the etiology of large bowel obstruction on unenhanced CT, an intravenous contrast agent may be avoided for the identification of the etiology. In remaining cases, contrast agent is still recommended.

Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.

Radiology ◽  
1996 ◽  
Vol 198 (2) ◽  
pp. 365-370 ◽  
Author(s):  
L Harika ◽  
R Weissleder ◽  
K Poss ◽  
M I Papisov
Keyword(s):  
Contrast Agent ◽  
Intravenous Contrast ◽  
Mr Lymphography ◽  
Intravenous Contrast Agent ◽  
Efficacy Studies

Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer

2007 ◽  
Vol 21 (10) ◽  
pp. 585-592 ◽  
Author(s):  
Young-Sil An ◽  
Seung S. Sheen ◽  
Y. J. Oh ◽  
Sung C. Hwang ◽  
Joon-Kee Yoon
Keyword(s):  
Lung Cancer ◽  
Contrast Agent ◽  
Fdg Pet ◽  
Intravenous Contrast ◽  
Pet Ct ◽  
18F Fdg ◽  
Clinically Significant ◽  
Fdg Pet Ct ◽  
Intravenous Contrast Agent

HPLC Determination of Rubber Septum Contaminants in the Iodinated Intravenous Contrast Agent (Sodium Iothalamate)

1993 ◽  
Vol 17 (1) ◽  
pp. 34-37 ◽  
Author(s):  
Virindar S. Gaind ◽  
Kazik Jedrzejczak
Keyword(s):  
Contrast Agent ◽  
Hplc Determination ◽  
Intravenous Contrast ◽  
Intravenous Contrast Agent
Sign in / Sign up

Export Citation Format

Share Document